Find Clinical Trials & Studies
YKP3089C040
I'm Interested!
Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-onset (Focal) Seizures
- Sex at Birth: Any
- Age: Child (Birth - 17)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Epilepsy
Study Purpose
We are doing this study to see if Cenobamate helps reduce or stop partial onset seizures (POS) and see how safe it is for children taking it as a long term treatment.
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20221340
- StudyID: 2022-01093
- ClinicalTrials.gov: NCT05067634
I'm Interested!
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422